A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls

  title={A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls},
  author={Donald C. Goff and Lisa Sullivan and Joseph P. McEvoy and Jonathan M. Meyer and Henry A. Nasrallah and Gail L Daumit and Steven Lamberti and Ralph B. D'Agostino and T. Scott Stroup and Sonia M. Davis and Jeffrey A. Lieberman},
  journal={Schizophrenia Research},
Increased Framingham 10-year CVD risk in Chinese patients with schizophrenia
Cardiac risk factors and metabolic syndrome in patients with schizophrenia admitted to a general hospital psychiatric unit
Patients of schizophrenia have a high prevalence of MS and CVR factors and there is a need to screen the patient of schizophrenia for the same and manage the same as early as possible during the course of illness.
Coronary heart disease risk in patients with schizophrenia: a Lebanese cross-sectional study
CHD is prevalent in patients with schizophrenia in Lebanon and Physicians are recommended to monitor the components of the metabolic syndrome to identify patients with increased risk of cardiovascular diseases.
The Relationship between 10 Years Risk of Cardiovascular Disease and Schizophrenia Symptoms: Preliminary Results
A relationship between the risk of cardiovascular disease and the duration and overall severity of schizophrenia is suggested and the role of antipsychotics in this relationship is highlighted.
Cardiovascular disease mortality in patients with chronic schizophrenia treated with clozapine: a retrospective cohort study.
The risk of CVD mortality in schizophrenia does not differ between clozapine and risperidone in adults despite known differences in risk profiles for weight gain and metabolic side effects, however, one cannot rule out an increased risk ofCVD mortality among those starting treatment at ages 55 years or older.
Assessment of risk for cardiovascular disease in a sample of schizophrenic patients
The study points to the measurement of CRP and screening of lipid levels as an improved method for identifying schizophrenic patients at risk for cardiovascular events.
Metabolic syndrome and 10-year risk of cardiovascular events among schizophrenia inpatients treated with antipsychotics
Patients with schizophrenia showed a high prevalence of metabolic syndrome, but most of them had low risk of developing cardiovascular disease, and regular screening and early interventions to modify the risk factors of metabolic Syndrome are suggested.


Characterizing Coronary Heart Disease Risk in Chronic Schizophrenia: High Prevalence of the Metabolic Syndrome
These long-term patients with chronic schizophrenia or schizoaffective disorder have increased CHD risks best captured by the metabolic syndrome conceptualization coupled with a high rate of cigarette smoking, consistent with increased cardiovascular morbidity and decreased life expectancy in both men and women.
Serious Cardiovascular Events and Mortality Among Patients with Schizophrenia
Among patients with schizophrenia, cardiovascular risk was inversely associated with intensity of use of antipsychotic drugs, suggesting that the observed risks may not be due to a simple or direct effect of drugs.
The association between schizophrenia and cancer: a population-based mortality study
Prevalence and correlates of diabetes in national schizophrenia samples.
This study of diabetes in the early 1990s suggests that even before the widespread use of the atypical antipsychotic drugs, diabetes was a major problem for persons with schizophrenia.
Quality of medical care and excess mortality in older patients with mental disorders.
Deficits in quality of medical care seemed to explain a substantial portion of the excess mortality experienced by patients with mental disorders after myocardial infarction, and the potential importance of improving patients' medical care as a step toward reducing their excess mortality is suggested.
Time trends in schizophrenia mortality in Stockholm County, Sweden: cohort study
Assessment of mortality over time after a first admission to hospital with schizophrenia in Stockholm County found that over expected numbers of deaths and relative risks (95% confidence intervals) for different causes of death are similar.
Diet, smoking and cardiovascular risk in people with schizophrenia: descriptive study.
  • R. McCreadie
  • Medicine, Psychology
    The British journal of psychiatry : the journal of mental science
  • 2003
The lifestyle of people with schizophrenia must give cause for concern in relation to CHD, as described through diet, smoking habits, weight and exercise.
The distribution of body mass index among individuals with and without schizophrenia.
Although there may be a small subpopulation of schizophrenic individuals who are underweight, individuals with schizophrenia were, on the whole, as obese as or more obese than individuals without schizophrenia, suggesting that weight gain induced by antipsychotic agents is an important concern for many individuals.
Excess mortality of schizophrenia
  • Steve Brown
  • Medicine, Psychology
    British Journal of Psychiatry
  • 1997
The available evidence suggests that schizophrenia is associated with a large increase mortality from suicide and a moderate increased mortality from natural causes.